Some NBS programs for Pompe disease, including ours, have shown that the combination of GAA enzyme assays using dried-blood spot (DBS) cards and GAA gene mutation analysis could be useful in distinguishing false-positive cases from patients with Pompe disease. The gene discussed is GAA; the disease is Glycogen storage disease due to acid maltase deficiency.